Xenetic Biosciences Inc

+0.13 (+4.04%)
4:07:40 PM EDT: $3.30 -0.05 (-1.49%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)5.16M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.68 Million
Adjusted EPS-$0.87
See more estimates
10-Day MA$3.16
50-Day MA$3.80
200-Day MA$3.96
See more pivots

Xenetic Biosciences Inc Stock, NASDAQ:XBIO

945 Concord Street, Suite 102, Framingham, Massachusetts 01701
United States of America
Phone: +1.781.778.7720
Number of Employees: 4


Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient�s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.